Herpes labialis: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
mNo edit summary
mNo edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 1: Line 1:
In [[medicine]], '''Herpes labialis''' is a [[herpes simplex]] infection, caused by [[Human herpesvirus 1|type 1 virus]], primarily spread by oral secretions and usually occurring as a concomitant of [[fever]]. It may also develop in the absence of fever or prior illness. It commonly involves the facial region, especially the lips and the nares.<ref>{{MeSH}}</ref>
{{subpages}}
In [[medicine]], '''Herpes labialis''' is a [[herpes simplex]] infection, caused by [[Human herpesvirus 1|type 1 virus]], primarily spread by oral secretions and usually occurring as a concomitant of [[fever]]. It may also develop in the absence of fever or prior illness. It commonly involves the facial region, especially the lips and the nares.<ref>{{MeSH}}</ref> While Type 1 virus is most common in the mouth, it can infect the genitals, while Type 2 [[herpes genitalis]] can affect the mouth. The treatment of both is similar.


{{Image|Herpes labialis - opryszczka wargowa.jpg|left|350px| Cold sores are most commonly caused by [[Human herpesvirus 1]] and are ubiquitous in distribution in human populations. Here, the vesicles have crusted over and begun to heal.}}
==Clinical presentation==
{{Image|Herpes labialis - opryszczka wargowa.jpg|right|300px| Cold sores are most commonly caused by [[Human herpesvirus 1]] and are ubiquitous in distribution in human populations. Here, the vesicles have crusted over and begun to heal.}}


==Treatment==
==Treatment==
A [[systematic review of]] treatment options is available.<ref name="pmid18541820">{{cite journal| author=Cernik C, Gallina K, Brodell RT| title=The treatment of herpes simplex infections: an evidence-based review. | journal=Arch Intern Med | year= 2008 | volume= 168 | issue= 11 | pages= 1137-44 | pmid=18541820 | doi=10.1001/archinte.168.11.1137 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18541820  }} </ref>
A [[systematic review]] of treatment options is available.  It centers on antiviral agents such as [[acyclovir]], [[famciclovir]], and [[valacyclovir]], but in different dosing regimens for acute, intermittent prophylactic, and chronic prophylactic use.  Oral agents have proven effective, while topical preparations of the same drugs are discouraged. <ref name="pmid18541820">{{cite journal| author=Cernik C, Gallina K, Brodell RT| title=The treatment of herpes simplex infections: an evidence-based review. | journal=Arch Intern Med | year= 2008 | volume= 168 | issue= 11 | pages= 1137-44 | pmid=18541820 | doi=10.1001/archinte.168.11.1137 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18541820  }} </ref>


==References==
==References==
<references/>
<references/>[[Category:Suggestion Bot Tag]]

Latest revision as of 11:01, 27 August 2024

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, Herpes labialis is a herpes simplex infection, caused by type 1 virus, primarily spread by oral secretions and usually occurring as a concomitant of fever. It may also develop in the absence of fever or prior illness. It commonly involves the facial region, especially the lips and the nares.[1] While Type 1 virus is most common in the mouth, it can infect the genitals, while Type 2 herpes genitalis can affect the mouth. The treatment of both is similar.

Clinical presentation

Cold sores are most commonly caused by Human herpesvirus 1 and are ubiquitous in distribution in human populations. Here, the vesicles have crusted over and begun to heal.

Treatment

A systematic review of treatment options is available. It centers on antiviral agents such as acyclovir, famciclovir, and valacyclovir, but in different dosing regimens for acute, intermittent prophylactic, and chronic prophylactic use. Oral agents have proven effective, while topical preparations of the same drugs are discouraged. [2]

References